Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 8754051
Peptide modulators of the δPKC interaction with the d subunit of F1Fo ATP synthase/ATPase and uses thereof
granted -
US 8754034
Structure-based design of peptide inhibitors of amyloid fibrillation
granted -
US 8754044
Neuroprotection by hepatic cells and hepatocyte secretory factors
granted -
US 8754050
Macrocyclic compounds useful as inhibitors of histone deacetylases
granted -
US 8754081
Compositions and methods for inhibition of hepatocyte growth factor receptor c-Met signaling
granted -
US 8754124
Oligo-benzamide compounds and their use in treating cancers
granted -
US 8754564
Hydrogel implants with varying degrees of crosslinking
granted -
US 8754108
Freeze-dried pantoprazole preparation and pantoprazole injection
granted -
US 8754223
Crystalline form of a biphenyl compound
granted -
US 8754222
Process for preparing modulators of cystic fibrosis transmembrane conductance regulator
granted -
US 8754225
Process for preparing a biphenyl-2-ylcarbamic acid
granted -
US 8753646
IPV-DPT vaccine
granted -
US 8754233
Pyrazolylbenzothiazole derivatives and their use as therapeutic agents
granted -
US 8754224
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
granted -
US 8754218
Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives
granted -
US 8753649
Polysaccharide-protein conjugate vaccines
granted -
US 8754080
Pyrimidine substituted purine compounds as kinase (S) inhibitors
granted -
US 8754046
MHC class II restricted T cell epitopes from the cancer anitgen, NY ESO-1
granted -
US 8754030
Defensin-antigen fusion proteins
granted -
US 8748601
Selective serine/threonine kinase inhibitors
granted -
US 8748608
4-phenylpiperazine derivatives with functionalized linkers as dopamine D3 receptor selective ligands and methods of use
granted -
US 8748597
2,4-pyrimidinediamine compounds and their uses
granted -
US 8748573
Formulations comprising linaclotide
granted -
US 8748569
Peptide amphiphiles and methods to electrostatically control bioactivity of the ikvav peptide epitope
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.